Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych CASC / OSCEPsychopharmacology — pregnancy and lactation

Psych CASC / OSCE · Psychopharmacology — pregnancy and lactation

Counselling psychotropics in an unplanned pregnancy (CASC)

CASC-style station: shared decision on perinatal psychopharmacology — untreated illness risk, valproate switch hierarchy, lithium absolute-risk framing, and safety-net with obstetrics.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 29-year-old woman with bipolar I disorder and her partner attend after a positive home pregnancy test (about 5–6 weeks). She takes valproate 1000 mg daily and is terrified after reading online that 'all psychiatric drugs cause birth defects'. She wants to stop medication today. Partner asks whether lithium is 'poison'.

Station instructions (candidate)

You have 7 minutes. Explore understanding and fear without dismissing it. Explain why stopping everything today is not automatic. Name that valproate is the agent of greatest concern for major malformations and learning/developmental outcomes and outline a switch plan. Frame lithium with modern small absolute cardiac risk language if relevant to her history. Include postpartum risk, obstetric liaison, and a clear safety-net. Do not guarantee zero risk from any option.[1][2][4]

Marking domains

Agenda and empathy; accurate untreated bipolar/postpartum risk framing; correct valproate hierarchy (MCM + neurodevelopment); modern lithium absolute-risk counselling if discussed; shared decision without coercion; obstetric/perinatal psychiatry plan; crisis and early follow-up safety-net; invitation for partner questions. These domains match CASC priorities for perinatal medication stations.[1][2][3][5]

Model communication map

  1. Open: congratulate carefully; check dates, supports, and what they read online; name the shared goal — keep mother well and protect baby as much as evidence allows.[6]
  2. Illness first: bipolar can return if medicines stop suddenly; pregnancy does not protect; the weeks after birth are especially high risk for severe episodes.[1][5]
  3. Baseline risk: any pregnancy has roughly a 2–3% chance of a major birth difference without medicines — context for numbers.[4]
  4. Valproate truth: among mood medicines, valproate has the highest known risk of major birth defects and of effects on learning/development in children exposed in the womb — we plan to change off valproate urgently with specialist support, not continue it casually.[2][3]
  5. Lithium if offered: modern large studies show a small increase in heart differences, not the nightmare percentages of old stories; if lithium fits her history we use scans, blood levels, and a birth plan — a joint decision.[4]
  6. Today’s actions: obstetric confirmation, stop-switch plan written, who to call if mood rises or sleep collapses, early review, written information.[6]
  7. Close: partner questions; no guarantee of zero risk; no abandonment — we walk the pregnancy with them.[6]

Common fails

  • Agreeing to stop all medicines the same day without relapse framing.[1]
  • Minimising valproate risk or treating it as interchangeable with lithium.[2][3]
  • Calling lithium “poison” or “completely safe.”[4]
  • Ignoring postpartum peak risk.[5]
  • No obstetric liaison or follow-up plan.[6]

References

  1. [1]Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation Am J Psychiatry, 2007.PMID 18056236
  2. [2]Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry Lancet Neurol, 2011.PMID 21652013
  3. [3]Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs N Engl J Med, 2009.PMID 19369666
  4. [4]Patorno E, Huybrechts KF, Bateman BT, et al. Lithium Use in Pregnancy and the Risk of Cardiac Malformations N Engl J Med, 2017.PMID 28591541
  5. [5]Bergink V, Rasgon N, Wisner KL Postpartum Psychosis: Madness, Mania, and Melancholia in Motherhood Am J Psychiatry, 2016.PMID 27609245
  6. [6]Betcher HK, Wisner KL Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles J Womens Health (Larchmt), 2020.PMID 31800350